Population
Human platelets, murine platelets (including knockout mice deficient in P2Y1 or Galphai2), and RBL-2H3 cells
Design
Preclinical
Authors
Loading...
Does not alter antiplatelet regimens; leaves open PI3K/epinephrine targeting of P2Y12-independent Rap1 in future human studies.
This study defines the mechanisms of GPVI-mediated platelet activation, highlighting Rap1 as a key signaling protein activated via both P2Y12-dependent and -independent pathways.
Larson et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: